PHPB Attenuated Cognitive Impairment in Type 2 Diabetic KK-Ay Mice by Modulating SIRT1/Insulin Signaling Pathway and Inhibiting Generation of AGEs

被引:5
作者
Li, Jiang [1 ]
Xu, Shaofeng [1 ]
Wang, Ling [1 ]
Wang, Xiaoliang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
关键词
potassium 2-(1-hydroxypentyl)-benzoate (PHPB); diabetic encephalopathy (DE); advanced glycation end products (AGEs); insulin signaling pathway; oxidative stress; GLYCATION END-PRODUCTS; ALZHEIMERS-DISEASE; METHYLGLYOXAL; PLASTICITY; RATS;
D O I
10.3390/ph16020305
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Diabetes mellitus (DM) has been recognized as an increased risk factor for cognitive impairment, known as diabetic encephalopathy (DE). Hyperglycemia and insulin resistance are the main initiators of DE, which is related to the accumulation of advanced glycation end products (AGEs). Potassium 2-(1-hydroxypentyl)-benzoate (PHPB), a derivative of 3-n-butylphthalide (dl-NBP), has emerged various properties including improved mitochondrial function, antioxidant, anti-neuroinflammation, and neuroprotective effects. The present study aimed to investigate the neuroprotective effect of PHPB against AGEs accumulation in type 2 diabetic KK-Ay mice model with DE and further explore the underlying mechanisms. The results showed that PHPB markedly ameliorated the spatial learning ability of KK-Ay mice in the Morris water maze and decreased AD-like pathologic changes (Tau hyperphosphorylation) in the cortex. Furthermore, we found that PHPB treatment significantly reduced AGEs generation via up-regulation of glyoxalase-1 (GLO1) protein and enhancement of methylglyoxal (MG) trapping, while there was no obvious difference in levels of glucose in plasma or brain, contents of total cholesterol (TC), triglycerides (TG), and plasma insulin. Also, PHPB treatment improved the insulin signaling pathway by increasing sirtuin1 (SIRT1) deacetylase activity and attenuated oxidative stress evidenced by elevating glucose-6-phosphate dehydrogenase (G-6-PD) protein expression, promoting the production of reduced glutathione (GSH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH), restoring mitochondrial membrane potential, increasing adenosine triphosphate (ATP) generation, and reducing malondialdehyde (MDA) levels in the brain. Taken together, PHPB exhibited a beneficial effect on DE, which involved modulating the SIRT1/insulin signaling pathway and reducing oxidative stress by inhibiting the generation of AGEs.
引用
收藏
页数:17
相关论文
共 46 条
  • [1] Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment
    Ahmed, N
    Ahmed, U
    Thornalley, PJ
    Hager, K
    Fleischer, G
    Münch, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 92 (02) : 255 - 263
  • [2] Reduced Gap Junctional Communication Among Astrocytes in Experimental Diabetes: Contributions of Altered Connexin Protein Levels and Oxidative-Nitrosative Modifications
    Ball, Kelly K.
    Harik, Lamia
    Gandhi, Gautam K.
    Cruz, Nancy F.
    Dienel, Gerald A.
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (12) : 2052 - 2067
  • [3] Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease
    Batkulwar, Kedar
    Godbole, Rashmi
    Banarjee, Reema
    Kassaar, Omar
    Williams, Robert J.
    Kulkarni, Mahesh J.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2018, 9 (05): : 988 - 1000
  • [4] Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation
    Belanger, Mireille
    Allaman, Igor
    Magistretti, Pierre J.
    [J]. CELL METABOLISM, 2011, 14 (06) : 724 - 738
  • [5] Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
    Brier, Matthew R.
    Gordon, Brian
    Friedrichsen, Karl
    McCarthy, John
    Stern, Ari
    Christensen, Jon
    Owen, Christopher
    Aldea, Patricia
    Su, Yi
    Hassenstab, Jason
    Cairns, Nigel J.
    Holtzman, David M.
    Fagan, Anne M.
    Morris, John C.
    Benzinger, Tammie L. S.
    Ances, Beau M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (338)
  • [6] Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats
    Brouwers, Olaf
    Niessen, Petra M.
    Ferreira, Isabel
    Miyata, Toshio
    Scheffer, Peter G.
    Teerlink, Tom
    Schrauwen, Patrick
    Brownlee, Michael
    Stehouwer, Coen D.
    Schalkwijk, Casper G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (02) : 1374 - 1380
  • [7] AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING
    BROWNLEE, M
    VLASSARA, H
    KOONEY, A
    ULRICH, P
    CERAMI, A
    [J]. SCIENCE, 1986, 232 (4758) : 1629 - 1632
  • [8] Method for determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture
    Chaplen, FWR
    Fahl, WE
    Cameron, DC
    [J]. ANALYTICAL BIOCHEMISTRY, 1996, 238 (02) : 171 - 178
  • [9] Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease
    Chou, Ping-Song
    Wu, Meng-Ni
    Yang, Chen-Cheng
    Shen, Cheng-Ting
    Yang, Yuan-Han
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (01) : 191 - 197
  • [10] Advanced glycation end products in diabetes, cancer and phytochemical therapy
    Dariya, Begum
    Nagaraju, Ganji Purnachandra
    [J]. DRUG DISCOVERY TODAY, 2020, 25 (09) : 1614 - 1623